Volume12, Issue0 (2026)

Hepatoma Research

Search Submit

Hepatoma Research

ISSN 2454-2520 (Online) 2394-5079 (Print)

[email protected]

Navigation

Sitemap

LinkedIn
Twitter
Academia
Google Scholar

Navigation

Sitemap

Committee on Publication Ethics

https://members.publicationethics.org/members/hepatoma-research

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Committee on Publication Ethics

https://members.publicationethics.org/members/hepatoma-research

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Discover Content

Strategic Collaborators

Follow OAE

Privacy Cookies Terms of Service

Volume

Table of Contents (29 articles)

Review of advances in FOLFOX-HAIC for conversion, neoadjuvant, and adjuvant therapy in hepatocellular carcinoma

Hepatocellular carcinoma tumor immune microenvironment: heterogeneity and therapeutic strategies

A review on decellularization scaffolding for liver regeneration in transplantation

A systematic review of comparative economic analyses of systemic therapies for hepatocellular carcinoma

Regional dietary patterns and risk of primary liver cancer in anhui, china: a population-based case-control study

Targeting gut microbiota to overcome immunotherapy resistance in hepatocellular carcinoma: from mechanisms to clinical practice

Helicobacter pylori is associated with a higher risk of MAFLD prevalence and all-cause mortality: results from the NHANES III follow-up study

An activated CD8⁺ T cell-based signature stratifies prognosis and suggests differential sensitivity to immune checkpoint inhibitors in hepatocellular carcinoma

Incretin-based therapies: a new era in metabolic liver disease management

Yttrium-90 combination therapies in hepatocellular carcinoma: current evidence and future directions

Patient-derived tumor organoid models for functional precision oncology in hepatocellular carcinoma

Impact of metabolic reprogramming on the immune response in hepatocellular carcinoma

Conversion and neoadjuvant systemic therapy for intrahepatic cholangiocarcinoma: from technical resectability to biology-driven surgical selection - a systematic review and meta-analysis

Resistance to immune checkpoint inhibitors in hepatocellular carcinoma: mechanisms and combination strategies to overcome it

Histone lactylation in hepatocellular carcinoma: a key epigenetic hub linking metabolic reprogramming and the immune microenvironment

Emerging potential of CAR-NK cell therapy for hepatocellular carcinoma: current advances and translational challenges

Cordycepin alleviates oxaliplatin-induced fatty liver disease

Kupffer cells and monocyte-derived macrophages in the pathogenesis and treatment of hepatocellular carcinoma

Multi-task neural network enhanced by data augmentation and ROI optimization for prognosis and MVI prediction in HCC using contrast-enhanced CT

Reconstructing strategies for precision diagnosis and treatment of liver cancer based on multi-modal data

The role of “treatment unfeasibility” in the multiparametric, multidisciplinary, and expert evaluation of HCC patients

The evolving role of contrast-enhanced ultrasound in hepatocellular carcinoma: from diagnosis to therapeutic monitoring

Application of ex vivo liver perfusion in hepatoma research

Metabolic reprogramming and the tumor microenvironment in hepatocellular carcinoma: mechanisms and therapeutic targeting

Converse therapeutic hierarchy in hepatocellular carcinoma

Molecular characteristics of fatty acid metabolic reprogramming in hepatocellular carcinoma and their implications for immunotherapy

Exploring the molecular pathology and tumor microenvironment in gastric cancer liver metastasis

Rewiring the tumor microenvironment in hepatocellular carcinoma: mechanism-driven integration of immunotherapy and locoregional strategies

Controlled attenuation parameter factors and steatosis grading in metabolic dysfunction-associated steatotic liver disease

Actions for 0 selected articles

Committee on Publication Ethics

Portico

Committee on Publication Ethics

Portico

Volume

Table of Contents (29 articles)

Review of advances in FOLFOX-HAIC for conversion, neoadjuvant, and adjuvant therapy in hepatocellular carcinoma

Hepatocellular carcinoma tumor immune microenvironment: heterogeneity and therapeutic strategies

A review on decellularization scaffolding for liver regeneration in transplantation

A systematic review of comparative economic analyses of systemic therapies for hepatocellular carcinoma

Regional dietary patterns and risk of primary liver cancer in anhui, china: a population-based case-control study

Targeting gut microbiota to overcome immunotherapy resistance in hepatocellular carcinoma: from mechanisms to clinical practice

Helicobacter pylori is associated with a higher risk of MAFLD prevalence and all-cause mortality: results from the NHANES III follow-up study

An activated CD8+ T cell-based signature stratifies prognosis and suggests differential sensitivity to immune checkpoint inhibitors in hepatocellular carcinoma

Incretin-based therapies: a new era in metabolic liver disease management

Yttrium-90 combination therapies in hepatocellular carcinoma: current evidence and future directions

Patient-derived tumor organoid models for functional precision oncology in hepatocellular carcinoma

Impact of metabolic reprogramming on the immune response in hepatocellular carcinoma

Conversion and neoadjuvant systemic therapy for intrahepatic cholangiocarcinoma: from technical resectability to biology-driven surgical selection - a systematic review and meta-analysis

Resistance to immune checkpoint inhibitors in hepatocellular carcinoma: mechanisms and combination strategies to overcome it

Histone lactylation in hepatocellular carcinoma: a key epigenetic hub linking metabolic reprogramming and the immune microenvironment

Emerging potential of CAR-NK cell therapy for hepatocellular carcinoma: current advances and translational challenges

Cordycepin alleviates oxaliplatin-induced fatty liver disease

Kupffer cells and monocyte-derived macrophages in the pathogenesis and treatment of hepatocellular carcinoma

Multi-task neural network enhanced by data augmentation and ROI optimization for prognosis and MVI prediction in HCC using contrast-enhanced CT

Reconstructing strategies for precision diagnosis and treatment of liver cancer based on multi-modal data

The role of “treatment unfeasibility” in the multiparametric, multidisciplinary, and expert evaluation of HCC patients

The evolving role of contrast-enhanced ultrasound in hepatocellular carcinoma: from diagnosis to therapeutic monitoring

Application of ex vivo liver perfusion in hepatoma research

Metabolic reprogramming and the tumor microenvironment in hepatocellular carcinoma: mechanisms and therapeutic targeting

Converse therapeutic hierarchy in hepatocellular carcinoma

Molecular characteristics of fatty acid metabolic reprogramming in hepatocellular carcinoma and their implications for immunotherapy

Exploring the molecular pathology and tumor microenvironment in gastric cancer liver metastasis

Rewiring the tumor microenvironment in hepatocellular carcinoma: mechanism-driven integration of immunotherapy and locoregional strategies

Controlled attenuation parameter factors and steatosis grading in metabolic dysfunction-associated steatotic liver disease

Actions for 0 selected articles

Committee on Publication Ethics

Portico

Committee on Publication Ethics

Portico

An activated CD8⁺ T cell-based signature stratifies prognosis and suggests differential sensitivity to immune checkpoint inhibitors in hepatocellular carcinoma